Australia, Sept. 22 -- Belite Bio Inc., owns the trademark (2644911) for 'VUEKENSE' till March 6, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical and biopharmaceutical drugs and medicines for treatment of degenerative retinal diseases.], 42 [Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of degenerative retinal diseases; research and development in the pharmaceutical, life sciences and biotechnology fields.], 05 [] and 42 []
Type of Mark: Word
Date of Acceptance: May 11
Registration Advertised: Sept. 21
For further details contact Scott W. Pink O'Melveny & Myers LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2644911.
Disclaimer: Curated by HT Syndication.
